(Q34662190)

English

Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Vivian T Martins

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Miguel A Chávez-Fumagalli

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lourena E Costa

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Adriana M C Canavaci

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Adriana M C C Martins

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Paula S Lage

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Daniela P Lage

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mariana C Duarte

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Diogo G Valadares

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Rubens D M Magalhães

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tatiana G Ribeiro

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ronaldo A P Nagem

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Wanderson D Darocha

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Wiliam C B Régis

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Manuel Soto

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Eduardo A F Coelho

16

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ana Paula Fernandes

17

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Carlos A P Tavares

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

28 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PLoS Neglected Tropical Diseases

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

e2148

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

28 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Vaccine prospects of killed but metabolically active Leishmania against visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Current diagnosis and treatment of visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Cutaneous leishmaniasis treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Animal models for vaccine studies for visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Immunopathogenesis of infection with the visceralizing Leishmania species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Recent advances in vaccines for leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Immune response to Leishmania infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

RecombinantLeishmania majorSecreting Biologically Active Granulocyte-Macrophage Colony-Stimulating Factor Survives Poorly in Macrophages In Vitro and Delays Disease Development in Mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

IL-10 mediates susceptibility to Leishmania donovani infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Genetic susceptibility to leishmanial infections: studies in mice and man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from L-arginine by macrophages and hepatocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3610918

7 July 2018

Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002148

21 January 2018

Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002148

21 January 2018

Investigation of Chagas disease in four periurban areas in northeastern Brazil: epidemiologic survey in man, vectors, non-human hosts and reservoirs.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002148

21 January 2018

Trypanosoma cruzi among wild and domestic mammals in different areas of the Abaetetuba municipality (Pará State, Brazil), an endemic Chagas disease transmission area

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002148

21 January 2018

Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002148

21 January 2018

Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002148

21 January 2018

Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: A case report.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002148

21 January 2018

Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002148

21 January 2018

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002148

21 January 2018

Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002148

21 January 2018

Immunohistological features of visceral leishmaniasis in BALB/c mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23573301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23573301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leishmania major parasite stage-dependent host cell invasion and immune evasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/23573301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/23573301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of partial protection against Leishmania donovani by promastigote antigens in negatively charged liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23573301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/23573301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/23573301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/23573301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PNTD.0002148

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34662190&oldid=1865146091"